Literature DB >> 26226081

EPI-CT: design, challenges and epidemiological methods of an international study on cancer risk after paediatric and young adult CT.

Magda Bosch de Basea1, Mark S Pearce, Ausrele Kesminiene, Marie-Odile Bernier, Jérémie Dabin, Hilde Engels, Michael Hauptmann, Lucian Krille, Johanna M Meulepas, Lara Struelens, Sarah Baatout, Magnus Kaijser, Carlo Maccia, Andreas Jahnen, Isabelle Thierry-Chef, Maria Blettner, Christoffer Johansen, Kristina Kjaerheim, Arvid Nordenskjöld, Hilde Olerud, Jane A Salotti, Tina Veje Andersen, Martine Vrijheid, Elisabeth Cardis.   

Abstract

Computed tomography (CT) has great clinical utility and its usage has increased dramatically over the years. Concerns have been raised, however, about health impacts of ionising radiation exposure from CTs, particularly in children, who have a higher risk for some radiation induced diseases. Direct estimation of the health impact of these exposures is needed, but the conduct of epidemiological studies of paediatric CT populations poses a number of challenges which, if not addressed, could invalidate the results. The aim of the present paper is to review the main challenges of a study on the health impact of paediatric CTs and how the protocol of the European collaborative study EPI-CT, coordinated by the International Agency for Research on Cancer (IARC), is designed to address them. The study, based on a common protocol, is being conducted in Belgium, Denmark, France, Germany, the Netherlands, Norway, Spain, Sweden and the United Kingdom and it has recruited over one million patients suitable for long-term prospective follow-up. Cohort accrual relies on records of participating hospital radiology departments. Basic demographic information and technical data on the CT procedure needed to estimate organ doses are being abstracted and passive follow-up is being conducted by linkage to population-based cancer and mortality registries. The main issues which may affect the validity of study results include missing doses from other radiological procedures, missing CTs, confounding by CT indication and socioeconomic status and dose reconstruction. Sub-studies are underway to evaluate their potential impact. By focusing on the issues which challenge the validity of risk estimates from CT exposures, EPI-CT will be able to address limitations of previous CT studies, thus providing reliable estimates of risk of solid tumours and leukaemia from paediatric CT exposures and scientific bases for the optimisation of paediatric CT protocols and patient protection.

Entities:  

Mesh:

Year:  2015        PMID: 26226081     DOI: 10.1088/0952-4746/35/3/611

Source DB:  PubMed          Journal:  J Radiol Prot        ISSN: 0952-4746            Impact factor:   1.394


  16 in total

Review 1.  Clinical pediatric positron emission tomography/magnetic resonance program: a guide to successful implementation.

Authors:  Sandra Saade-Lemus; Elad Nevo; Iman Soliman; Hansel J Otero; Ralph W Magee; Elizabeth T Drum; Lisa J States
Journal:  Pediatr Radiol       Date:  2020-02-19

2.  Cohort Profile: the EPI-CT study: a European pooled epidemiological study to quantify the risk of radiation-induced cancer from paediatric CT.

Authors:  Marie-Odile Bernier; Hélène Baysson; Mark S Pearce; Monika Moissonnier; Elisabeth Cardis; Michael Hauptmann; Lara Struelens; Jeremie Dabin; Christoffer Johansen; Neige Journy; Dominique Laurier; Maria Blettner; Lucian Le Cornet; Roman Pokora; Patrycja Gradowska; Johanna M Meulepas; Kristina Kjaerheim; Tore Istad; Hilde Olerud; Aste Sovik; Magda Bosch de Basea; Isabelle Thierry-Chef; Magnus Kaijser; Arvid Nordenskjöld; Amy Berrington de Gonzalez; Richard W Harbron; Ausrele Kesminiene
Journal:  Int J Epidemiol       Date:  2019-04-01       Impact factor: 7.196

Review 3.  Enhanced radiation dose and DNA damage associated with iodinated contrast media in diagnostic X-ray imaging.

Authors:  Richard Harbron; Elizabeth A Ainsbury; Simon D Bouffler; Rick J Tanner; Jonathan S Eakins; Mark S Pearce
Journal:  Br J Radiol       Date:  2017-08-22       Impact factor: 3.039

4.  High CT doses return to the agenda.

Authors:  W Rühm; R M Harrison
Journal:  Radiat Environ Biophys       Date:  2019-12-16       Impact factor: 1.925

5.  Individual radiation exposure from computed tomography: a survey of paediatric practice in French university hospitals, 2010-2013.

Authors:  Neige M Y Journy; Serge Dreuil; Nathalie Boddaert; Jean-François Chateil; Didier Defez; Hubert Ducou-le-Pointe; Jean-Marc Garcier; Joël Guersen; Bouchra Habib Geryes; Andreas Jahnen; Choonsik Lee; Jacqueline Payen-de-la-Garanderie; Jean-Pierre Pracros; Dominique Sirinelli; Isabelle Thierry-Chef; Marie-Odile Bernier
Journal:  Eur Radiol       Date:  2017-08-23       Impact factor: 5.315

6.  Studies of radiation health effects inform EPA actions.

Authors:  David Pawel; Michael Boyd
Journal:  J Radiol Prot       Date:  2019-05-14       Impact factor: 1.394

7.  Computed Tomography in Germany.

Authors:  Roman Pokora; Lucian Krille; Steffen Dreger; Choonsik Lee; Christian Günster; Hajo Zeeb; Maria Blettner
Journal:  Dtsch Arztebl Int       Date:  2016-10-28       Impact factor: 5.594

Review 8.  Epidemiological studies of CT scans and cancer risk: the state of the science.

Authors:  Amy Berrington de Gonzalez; Elisa Pasqual; Lene Veiga
Journal:  Br J Radiol       Date:  2021-10-01       Impact factor: 3.629

Review 9.  Advances in radiotherapy technology for pediatric cancer patients and roles of medical physicists: COG and SIOP Europe perspectives.

Authors:  Chia-Ho Hua; Anthony E Mascia; Enrica Seravalli; Antony J Lomax; Klaus Seiersen; Kenneth Ulin
Journal:  Pediatr Blood Cancer       Date:  2021-05       Impact factor: 3.167

10.  Radiation Exposure From Pediatric CT Scans and Subsequent Cancer Risk in the Netherlands.

Authors:  Johanna M Meulepas; Cécile M Ronckers; Anne M J B Smets; Rutger A J Nievelstein; Patrycja Gradowska; Choonsik Lee; Andreas Jahnen; Marcel van Straten; Marie-Claire Y de Wit; Bernard Zonnenberg; Willemijn M Klein; Johannes H Merks; Otto Visser; Flora E van Leeuwen; Michael Hauptmann
Journal:  J Natl Cancer Inst       Date:  2019-03-01       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.